What Is Fentanyl Citrate Solubility UK And Why Is Everyone Dissing It

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This article is intended for educational and expert info functions just. Fentanyl citrate is a Class A controlled substance in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formulation need to just be performed by certified professionals in regulated environments.

In the world of pharmacology and scientific medicine, fentanyl citrate remains one of the most powerful artificial opioids available. Due to its high efficacy and rapid onset of action, it is a foundation of pain management and anaesthesia in the UK's National Health Service (NHS) and personal healthcare sectors. However, the medicinal effectiveness of any drug is fundamentally connected to its physicochemical homes-- specifically its solubility.

Understanding the solubility of fentanyl citrate is essential for pharmacists, scientists, and clinicians to guarantee stable formulations, accurate dosing, and effective drug shipment throughout numerous administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is extremely lipophilic (fat-soluble), it possesses limited solubility in liquid environments. By reacting the base with citric acid, moving into the salt kind (fentanyl citrate), the solubility in water is significantly improved. This makes it suitable for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is manufactured according to the requirements set by the British Pharmacopoeia (BP). It generally appears as a white, crystalline powder or as granules that are odorless.

Secret Physicochemical Properties

Residential or commercial property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Around 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate varies dramatically depending


on the solvent used and the ambient temperature level. In

a pharmaceutical setting, water is the main solvent of interest for injectables, however natural solvents are frequently made use of during the manufacturing of transdermal patches or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most typically encountered as a 50 mcg/mL solution for injection. At space temperature level(roughly 20 ° C to 25 ° C), fentanyl

citrate is thought about"sparingly soluble"in water. Scientific literature normally suggests a solubility limitation of approximately 25 mg/mL in water at 25 ° C, which is more than adequate for basic medical concentrations. Organic Solvent Solubility Fentanyl citrate exhibits varied solubility in organic solvents, which is critical for formulating non-aqueous drug delivery systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Moderately Soluble ~ 25 mg/mL Methanol Easily Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Somewhat Soluble

<10 mg/mL Factors Influencing Solubility and Stability The solubility of fentanyl citrate is not a static worth; it

is influenced by a number of environmental and chemical factors that must be controlled during intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate remains highly soluble in acidic to neutral solutions. Most UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of a solution increases considerably above 7.5, there is a risk that the fentanyl


will transition back into its base form. Since the base

kind is considerably less soluble in water, this can result in"crashing out"or precipitation, which is extremely harmful in an IV setting. 2. Temperature level Effects Like a lot of crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is handy during the commercial dissolution procedure, it poses a threat throughout storage . If learn more is prepared at a high temperature and after that cooled (such as during transportation in cold UK winter seasons), the solute may take shape. 3. Presence of Other Ions(Common **Ion Effect )The existence of other citrate salts in the solution can reduce the solubility of fentanyl citrate due to the common ion impact. This is a necessary factor to consider when blending fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The option of buffer(e.g., sodium citrate or phosphate buffers)is

vital in preserving a stable environment where the drug remains in its ionized, soluble kind. Creating for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medical products must comply with the British Pharmacopoeia(BP). The BP supplies particular monographs for Fentanyl Citrate, making sure pureness, strength, and solubility standards are satisfied. Secret Compounding and Formulation Rules: Clarity of Solution: The BP needs that parenteral solutions be clear and devoid of noticeable particles. This is attained by guaranteeing the concentration stays well listed below the saturation point. Sterility: Given the liquid nature of the solution, solutions need to be

### disinfected, usually

by means of autoclaving or filtration, which can impact the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl solutions consist of Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH change). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the health care professional? Avoiding Precipitation: Knowing that fentanyl is incompatible with extremely alkaline

**services(like thiopentone or some bicarbonate solutions

*   **)avoids the formation of precipitates that might trigger embolic occasions. Enhancing Drug Delivery: In the development of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug must liquify*   **quickly in the little volume of saliva available. Transdermal Flux: While patches depend on the lipophilicity of the fentanyl base, the manufacture of these spots typically involves dissolving the citrate salt in an unstable solvent*   **before it is fertilized into the adhesive matrix. Storage and Handling Recommendations To keep the solubility and efficacy of fentanyl citrate products, the following guidelines are usually

            * * *

            followed in British medical settings: Temperature
            -------------------------------------------------

            Control: Store at controlled room temperature level (15 ° C to 25 ° C). Prevent freezing, as this can cause irreparable precipitation in**particular formulas. Light** Protection: Fentanyl citrate is rather light-sensitive. Liquid services should be kept in amber glass or opaque packaging. Dealing with Potency: Because of its high solubility and strength, accidental skin contact*   **with focused services** can lead to systemic absorption. Professional PPE is compulsory. Frequently Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is developed specifically to increase liquid solubility, making it ideal for injections. The base type is highly lipophilic and is typically utilized in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)vary

                from the USP relating to solubility? The basic

                solubility profiles equal as they explain the very same chemical entity. However, the specific testing methods and the prioritized solvents for pureness screening might differ

                *   **a little in between the BP** and the United States Pharmacopeia (USP). Can I mix fentanyl citrate with saline? Yes. Fentanyl citrate is compatible with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents utilized in UK health centers. What occurs if a fentanyl service becomes cloudy? If a service of fentanyl citrate appears cloudy or contains** crystals, it needs to be discarded. This suggests that the drug has sped up out of the solution, either due to pH modifications, temperature level shifts, or contamination.

                * * *

                Why is citric acid utilized particularly?
                -----------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade natural acid. It forms a stable salt with fentanyl that uses a balance of high water solubility and suitable pH for human tissue. Fentanyl citrate is a vital medicinal tool in the UK, but its security and efficacy are predicated on

                ### its chemical stability. Solubility is possibly the most critical factor in this regard

                . By keeping an ideal pH, selecting the appropriate solvents, and sticking to British Pharmacopoeia standards, the pharmaceutical industry guarantees that this potent analgesic remains a dependable option for client care.

                ### For clinicians, the takeaway is easy: constantly validate compatibility before blending and guarantee storage conditions are strictly met to prevent the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 20 May 2026 17:24 UTC

Views: 3